← Evidence map

ArticleFunctional & integrative genomics2024

CRISPR-Cas9-mediated deletion enhancer of MECOM play a tumor suppressor role in ovarian cancer.

Yujie Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38995475